WO2001085956A3 - Lipid metabolism enzymes - Google Patents

Lipid metabolism enzymes Download PDF

Info

Publication number
WO2001085956A3
WO2001085956A3 PCT/US2001/015210 US0115210W WO0185956A3 WO 2001085956 A3 WO2001085956 A3 WO 2001085956A3 US 0115210 W US0115210 W US 0115210W WO 0185956 A3 WO0185956 A3 WO 0185956A3
Authority
WO
WIPO (PCT)
Prior art keywords
lipid metabolism
lme
metabolism enzymes
provides
polynucleotides
Prior art date
Application number
PCT/US2001/015210
Other languages
French (fr)
Other versions
WO2001085956A2 (en
Inventor
Debopriya Das
Roopa Reddy
Monique G Yao
Danniel B Nguyen
Yan Lu
Catherine M Tribouley
Henry Yue
Farrah A Khan
Ameena R Gandhi
Janice Au-Young
Preeti Lal
Liam Kearney
Vicki S Elliott
Li Ding
Michael Thornton
Original Assignee
Incyte Genomics Inc
Debopriya Das
Roopa Reddy
Monique G Yao
Danniel B Nguyen
Yan Lu
Catherine M Tribouley
Henry Yue
Farrah A Khan
Ameena R Gandhi
Janice Au-Young
Preeti Lal
Liam Kearney
Vicki S Elliott
Li Ding
Michael Thornton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Debopriya Das, Roopa Reddy, Monique G Yao, Danniel B Nguyen, Yan Lu, Catherine M Tribouley, Henry Yue, Farrah A Khan, Ameena R Gandhi, Janice Au-Young, Preeti Lal, Liam Kearney, Vicki S Elliott, Li Ding, Michael Thornton filed Critical Incyte Genomics Inc
Priority to EP01935320A priority Critical patent/EP1280918A2/en
Priority to US10/275,998 priority patent/US20040023354A1/en
Priority to JP2001582545A priority patent/JP2004513611A/en
Priority to CA002407864A priority patent/CA2407864A1/en
Priority to AU2001261424A priority patent/AU2001261424A1/en
Publication of WO2001085956A2 publication Critical patent/WO2001085956A2/en
Publication of WO2001085956A3 publication Critical patent/WO2001085956A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.
PCT/US2001/015210 2000-05-11 2001-05-11 Lipid metabolism enzymes WO2001085956A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP01935320A EP1280918A2 (en) 2000-05-11 2001-05-11 Lipid metabolism enzymes
US10/275,998 US20040023354A1 (en) 2001-05-11 2001-05-11 Lipid metabolism enzymes
JP2001582545A JP2004513611A (en) 2000-05-11 2001-05-11 Lipid metabolizing enzymes
CA002407864A CA2407864A1 (en) 2000-05-11 2001-05-11 Lipid metabolism enzymes
AU2001261424A AU2001261424A1 (en) 2000-05-11 2001-05-11 Lipid metabolism enzymes

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US20351100P 2000-05-11 2000-05-11
US60/203,511 2000-05-11
US20790300P 2000-05-25 2000-05-25
US60/207,903 2000-05-25
US21015000P 2000-06-07 2000-06-07
US60/210,150 2000-06-07
US21339200P 2000-06-23 2000-06-23
US60/213,392 2000-06-23

Publications (2)

Publication Number Publication Date
WO2001085956A2 WO2001085956A2 (en) 2001-11-15
WO2001085956A3 true WO2001085956A3 (en) 2002-09-19

Family

ID=27498501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/015210 WO2001085956A2 (en) 2000-05-11 2001-05-11 Lipid metabolism enzymes

Country Status (5)

Country Link
EP (1) EP1280918A2 (en)
JP (1) JP2004513611A (en)
AU (1) AU2001261424A1 (en)
CA (1) CA2407864A1 (en)
WO (1) WO2001085956A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090323A2 (en) * 2000-05-19 2001-11-29 Millennium Pharmaceuticals, Inc. 46638, a putative family member of human lipoxygenase
US6812017B2 (en) 2000-10-11 2004-11-02 Centre National De La Recherche Scientique - Cnrs Mammalian secreted group IIF phospholipase A2
AU2001283321A1 (en) 2000-11-08 2002-05-21 Millennium Pharmaceuticals, Inc. A human phospholipase c and uses thereof
WO2003033689A1 (en) * 2001-10-12 2003-04-24 Centre National De La Recherche Scientifique -Cnrs- Cloning and recombinant expression of mammalian secreted group iif phopholipase a2

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0731164A1 (en) * 1993-09-24 1996-09-11 Shionogi & Co., Ltd. HUMAN PHOSPHOLIPASE C-$g(a) AND DNA SEQUENCE CODING FOR THE SAME
WO2001073027A2 (en) * 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0731164A1 (en) * 1993-09-24 1996-09-11 Shionogi & Co., Ltd. HUMAN PHOSPHOLIPASE C-$g(a) AND DNA SEQUENCE CODING FOR THE SAME
WO2001073027A2 (en) * 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ALVAREZ RICHARD A ET AL: "CDNA sequence and gene locus of the human retinal phosphoinositide-specific phospholipase C-beta-4 (PLCB4).", GENOMICS, vol. 29, no. 1, 1995, pages 53 - 61, XP001064391, ISSN: 0888-7543 *
DATABASE EMBL 12 June 1993 (1993-06-12), FERREIRA P A ET AL: "Bovine phospholipase C mRNA, 3' end of cds.", XP002193223 *
DATABASE EMBL 21 April 1995 (1995-04-21), ALVAREZ R A ET AL: "Homo sapiens phospholipase C beta 4 (PLCB4) mRNA, complete cds.", XP002193222 *
DATABASE EMBL 4 October 1993 (1993-10-04), LEE C W ET AL: "Rattus norvegicus phospholipase C beta4 mRNA, complete cds.", XP002193224 *
FERREIRA PAULO A ET AL: "Distinctive subtypes of bovine phospholipase C that have preferential expression in the retina and high homology to the norpA gene product of Drosophila.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 90, no. 13, 1993, 1993, pages 6042 - 6046, XP002193221, ISSN: 0027-8424 *
LEE C-W ET AL: "PURIFICATION, MOLECULAR CLONING, AND SEQUENCING OF PHOSPHOLIPASE C-BETA4", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 268, no. 28, 5 October 1993 (1993-10-05), pages 21318 - 21327, XP002013539, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2001261424A1 (en) 2001-11-20
JP2004513611A (en) 2004-05-13
WO2001085956A2 (en) 2001-11-15
EP1280918A2 (en) 2003-02-05
CA2407864A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
WO2003052075A3 (en) Enzymes
WO2001007628A3 (en) Human synthetases
WO2002063005A3 (en) Lipid-associated molecules
WO2001090334A3 (en) Drug metabolizing enzymes
WO2001051638A3 (en) Drug metabolizing enzymes
WO2002004612A3 (en) Drug metabolizing enzymes
WO2001016334A3 (en) Human hydrolytic enzymes
WO2003042357A3 (en) Enzymes
WO2001053468A3 (en) Lipid metabolism enzymes and polynucleotides encoding them
WO2001096546A3 (en) Protein phosphatases
WO2002026950A3 (en) Transferases
WO2001098471A8 (en) Human phosphodiesterases
WO2001032888A3 (en) Human transferase molecules
WO2002010363A3 (en) Protein phosphatases
WO2001064907A3 (en) Lipid metabolism enzymes
WO2001059127A3 (en) Drug metabolizing enzymes
WO2001079468A3 (en) Drug metabolizing enzymes
WO2002024924A3 (en) Protein phosphatases
WO2001083524A3 (en) Rna metabolism proteins
WO2002004490A3 (en) Lipid metabolism molecules
WO2001085956A3 (en) Lipid metabolism enzymes
WO2002012467A3 (en) Drug metabolizing enzymes
WO2002064795A3 (en) Putative human enzymes
WO2004003162A3 (en) Enzymes
WO2001055358A3 (en) Phosphodiesterases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2407864

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001935320

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001935320

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10275998

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001935320

Country of ref document: EP